Prevalence of Erythrocytosis and Associated Clinical Manifestations in Renal Transplant Recipients



Abstract Views
343

Downloads
242

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Mar 9, 2023
Published Jul 15, 2023
10.24018/ejmed.2023.5.4.1715

Abstract viewed = 343 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Erythrocytosis, also known as polycythemia is commonly defined as increase in red blood cells (RBCs) or hemoglobin concentration in the body. Polycythemia can cause blood clots and increases the risk of life threatening thromboembolic complications such as, pulmonary embolism, stroke, deep vein thrombosis (DVT), and heart attack. PTE is frequently seen among renal transplant recipients with an incidence of 10-15%, however, higher prevalence has been recorded in other communities worldwide. Risk factors associated with PTE development include male gender, renal artery stenosis, retained native kidney, hypertension, hydronephrosis, and diabetes. Role of sex hormones, smoking, polycystic kidney disease, inhibition of renin -angiotensin aldosterone system, and excessive use of immunosuppressive medications, mainly containing mycophenolic acid derivate, have been well documented. Onset of erythrocytosis is usually seen by 8 to 24 months in well- functioning grafts. In some patients it resolves spontaneously, whereas in others, can persist for more than two years. Common clinical symptoms associated with PTE are headache, vision problem, lethargy, dizziness, plethora, and increased risk of thromboembolic phenomena, including deep venous thrombosis (DVT), stroke, myocardial infarction (MI), though some patients remained asymptomatic. To study this a retrospective single-center study was conducted at Pakistan Kidney and Liver Institute & Research Centre. Our study showed that out of a total population of 80 recipients, 31.2% of patients (n=25) developed PTE while 68.8% of patients (n=55) did not develop PTE. We also found that in 60% of the patients (n=15), polycythemia resolved within 6 months. It was also found that male gender was at increased risk of erythrocytosis, indicating strong association (p=0.02). Our study did not show any co-relationship between PTE and other predisposing factors as previously reported. A larger trial with prospective analysis is needed to find any significant association.

Keywords: erythrocytosis erythroprotein kidney transplant post transplant erythrocytosis

Downloads

Download data is not yet available.

References

  1. McMullin MF: The classification and diagnosis of erythrocytosis. International journal of laboratory hematology. 2008, 30:447-59. 10.1111/j.1751-553X.2008.01102.x.
    DOI  |   Google Scholar
  2. Vlahakos DV, Marathias KP, Agroyannis B, Madias NE: Posttransplant erythrocytosis. Kidney international. 20031, 63:1187-94. 10.1046/j.1523-1755.2003.00850.x.
    DOI  |   Google Scholar
  3. Alzoubi B, Kharel A, Machhi R, Aziz F, Swanson KJ, Parajuli S.: Post-transplant erythrocytosis after kidney transplantation: A review. World Journal of Transplantation. 2021, 6:220. 10.5500/wjt.v11.i6.220.
    DOI  |   Google Scholar
  4. Charfeddine K, Zaghdane S, Yaich S, Hakim A, Hachicha J. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study. Saudi Journal of Kidney Diseases and Transplantation. 20081, 19:371.
     Google Scholar
  5. Razeghi E, Kaboli A, Pezeshki ML, Meysamie AP, Khatami MR, Khashayar P. Risk factors of erythrocytosis post renal transplantation. Saudi Journal of Kidney Diseases and Transplantation. 20081, 19:559.
     Google Scholar
  6. Abdelrahman M, Rafi A, Ghacha R, Qayyum T, Karkar A: Post-transplant erythrocytosis: a review of 47 renal transplant recipients. Saudi Journal of Kidney Diseases and Transplantation. 2004, 1:433.
     Google Scholar
  7. Rajasekar D, Dhanapriya J, Dineshkumar T, Sakthirajan R, Balasubramaniyan T, Gopalakrishnan N, et al. Erythrocytosis in renal transplant recipients: A single-center experience. Indian Journal of Transplantation. 2018112, 182. 10.4103/ijot.ijot_32_18.
     Google Scholar
  8. Ahmed S, Ahmed E, Naqvi R, Qureshi S. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients. Age (years). 2012, 1:28-69.
     Google Scholar
  9. Khan AA, Ayub H, Ahmed W, Khan AW. Post renal transplant polycythemia and treatment-single center study. Journal of the Pakistan Medical Association. 2021, 71:1-2. 10.47391/JPMA.1140.
    DOI  |   Google Scholar
  10. Frei D, Guttmann RD, Gorman P: A matched-pair control study of postrenal transplant polycythemia. American Journal of Kidney Diseases. 19821, 2:36-42. 10.1016/S0272-6386(82)80041-3.
    DOI  |   Google Scholar
  11. Perazella MA, Bia MJ. Posttransplant erythrocytosis. Case report and review of the newer treatment modalities. J Am Soc Nephrol. 1993, 3:1653-9. 10.1681/ASN.V3101653.
    DOI  |   Google Scholar
  12. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009, 9:1-55. 10.1038/ki.2009.377.
    DOI  |   Google Scholar
  13. Gaston RS, Julian BA, Curtis JJ. Posttransplant erythrocytosis: an enigma revisited. American Journal of Kidney Diseases. 1994 July, 1-24:1-11. 10.1016/S0272-6386(12)80153-3.
    DOI  |   Google Scholar
  14. Kessler M, Hestin D, Mayeux D, Mertes PM, Renoult E. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study. Clin Nephrol. 1996, 83-9.
     Google Scholar
  15. Yeter HH, Fettahoglu F, Yesiloglu E, Akcay O, Korucu B, Bali M, Derici U: Risk factors for posttransplant erythrocytosis: parathyroid hormone paradox?. Exp Clin Trans. 2020.
    DOI  |   Google Scholar
  16. Bacon BR, Rothman SA, Ricanati ES, Rashad FA. Renal artery stenosis with erythrocytosis after renal transplantation. Arch Intern Med. 1980, 140:1206-11. 10.1001/archinte.1980.00330200082025.
    DOI  |   Google Scholar
  17. Friman S, Nyberg G, Blohme l: Erythrocytosis after renal transplantation: treatment by removal of the native kidneys. Nephrol Dial Transplant. 1990, 5:969-73. 10.1093/ndt/5.11.969.
    DOI  |   Google Scholar
  18. Gross M, Goldwasser E. On the mechanism of erythropoietin-induced differentiation. XIV. The apparent effect of etiocholanolone on initiation of. erythropoiesis. Exp Hematol. 1976, 4:227.
     Google Scholar
  19. Nielsen AH, Johannessen A, Poulsen K. Inactive plasma renin exhibits sex difference in mice. Clin Sci (Lond. 1989, 76:439. 10.1042/cs0760439.
    DOI  |   Google Scholar
  20. Zanjani ED, Banisadre M. Hormonal stimulation of erythropoietin production and erythropoiesis in anephric sheep fetuses. J Clin Invest. 1979, 64:1181. 10.1172/JCI109571.
    DOI  |   Google Scholar
  21. Tirlapur VG, Gicheru K, Charalambous BM, Evans PJ, Mir MA. Packed cell volume, haemoglobin, and oxygen saturation changes in healthy smokers and non-smokers. Thorax. 1983, 38:785.
    DOI  |   Google Scholar
  22. Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA. 1990, 264:1556. 10.1001/jama.1990.03450120068031.
    DOI  |   Google Scholar
  23. Eisenga MF, Kieneker LM, Touw DJ, Nolte IM, Meer PVD, Huls G, et al. Active smoking and hematocrit and fasting circulating erythropoietin concentrations in the general population. Mayo Clin Proc. 2018, 93:337. 10.1016/j.mayocp.2018.01.005.
    DOI  |   Google Scholar
  24. Chandra M, Miller ME, Garcia JF, Mossey RT, McVicar M. Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. Nephron. 1985, 39:26. 10.1159/000183332.
    DOI  |   Google Scholar
  25. Eckardt KU, Mollmann M, Neumann R, Brunkhorst R, Burger HU, Lonnemann G, et al. Erythropoietin in polycystic kidneys. J Clin Invest. 1989, 84:1160. 10.1172/JCI114280.
    DOI  |   Google Scholar
  26. Gabow PA: Autosomal dominant polycystic kidney disease. New Engl J Med. 1993, 329:332. 10.1056/NEJM199307293290508.
    DOI  |   Google Scholar
  27. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med. 1990, 323:1091-6. 10.1056/NEJM199010183231602.
    DOI  |   Google Scholar
  28. Jensen JD, Hansen HE, Pedersen EB. Increased serum erythropoietin level during azathioprine treatment in renal transplant recipients. Nephron. 1994, 67:297-301. 10.1159/000187982.
    DOI  |   Google Scholar
  29. Webb DB, Price KA, Hutton RD, Newcombe RG, Salaman JR, Orchard J. Polycythaemia following renal transplantation: an association with azathioprine dosage?. American journal of nephrology. 1987:221-5. 10.1159/000167467.
    DOI  |   Google Scholar
  30. Einollahi B, Lessan-Pezeshki M, Nafar M, Pour-Reza-Gholi F, Firouzan A, Farhangi F, et al. Erythrocytosis after renal transplantation: review of 101 cases. In Transplantation proceedings. 20051, 37:3101-3102. 10.1016/j.transproceed.2005.08.023.
    DOI  |   Google Scholar
  31. Wickre CG, Norman DJ, Bennison A, Barry JM, Bennett WM. Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int. 1983, 23:731. 10.1038/ki.1983.86.
    DOI  |   Google Scholar
  32. Glicklich D, Tellis VA, Matas AJ, Mallis M, Quinn T, Soberman R, et al. No association between post-transplant erythrocytosis, thromboembolic events and cyclosporine therapy. Kidney Int.1994, 46:5. 10.1038/ki.1994.411
     Google Scholar
  33. Danovitch GM, Jamgotchian NJ, Eggena PH, Paul W, Barrett JD, Wilkinson A, et al. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism. Transplantation. 1995 1, 60:132-7.
    DOI  |   Google Scholar
  34. Gaston RS, Julian BA, Diethelm AG, Curtis JJ. Effects of enalapril on erythrocytosis after renal transplantation. Annals of internal medicine. 1991, 15:954-5. 10.7326/0003-4819-115-12-954.
    DOI  |   Google Scholar
  35. Marubayashi S, Yamamoto H, Shibata S, Fudaba Y, Miyata Y, Fukuma K, et al. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis. Hiroshima journal of medical sciences. 1998, 1:121-4.
     Google Scholar
  36. Julian BA, Gaston RS, Barker CV, Krystal G, Diethelm AG, Curtis JJ. Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney international. 19941, 46:1397-403. 10.1038/ki.1994.411.
    DOI  |   Google Scholar
  37. Mazzali M, Alves Filho G. Use of aminophylline and enalapril in posttransplant polycythemia. Transplantation. 1998, 15:1461-4.
    DOI  |   Google Scholar


Most read articles by the same author(s)